Upload Avatar (500 x 500)
Feng Wang
wangfeng@ibp.ac.cn
Chinese, English
Beijing
University of Chinese Academy of Sciences
Life Sciences
Antibody Engineering
Chemical Biology
Biophysics
Pharmacology
Immunology
Protein Engineering
Therapeutic Antibodies
Molecular Biology
Biotechnology
Drug Development
  • Site-specific Conjugation of a Selenopolypeptide to Alpha-1-antitrypsin Enhances Oxidation Resistance and Pharmacological Properties, Dong C, Wu GQ, Chen C, Li X, Yuan R, Xu L, Guo H, Zhang J, Lu H, Wang F, 2021
  • Epitope-directed antibody selection by site-specific photocrosslinking, Chen, Longxin, Zhu, Chaoyang, Guo, Hui, Li, Runting, Zhang, Limeng, Xing, Zhenzhen, Song, Yue, Zhang, Zihan, Wang, Fuping, Liu, Xiaofeng, Zhang, Yuhan, Ma, Runlin Z, Wang, Feng, 2020
  • Functional genetic encoding of sulfotyrosine in mammalian cells, Xinyuan He, Yan Chen, Daisy Guiza Beltran, Maia Kelly, Bin Ma, Justin Lawrie, Feng Wang, Eric Dodds, Limei Zhang, Jiantao Guo, Wei Niu, 2020
  • Complete genome of a unicellular parasite (Antonospora locustae) and transcriptional interactions with its host locust, Chen, Longxin, Gao, Xingke, Li, Runting, Zhang, Limeng, Huang, Rui, Wang, Linqing, Song, Yue, Xing, Zhenzhen, Liu, Ting, Nie, Xiaoning, Nie, Fangyuan, Hua, Shuang, Zhang, Zihan, Wang, Feng, Ma, Runlin Z, Zhang, Long, 2020
  • A tumor-targeted immune checkpoint blocker, Zhang, Yuhan, Fang, Changming, Wang, Rongsheng E, Wang, Ying, Guo, Hui, Guo, Chao, Zhao, Lijun, Li, Shuhong, Li, Xia, Schultz, Peter G, Cao, Yu J, Wang, Feng, 2019
  • Animal protein toxins: origins and therapeutic applications, Chen Na, Xu Siqi, Zhang Yuhan, Wang Feng, 2018
  • Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity, Harbut, Michael B, Yang, Baiyuan, Liu, Renhe, Yano, Takahiro, Vilcheze, Catherine, Cheng, Bo, Lockner, Jonathan, Guo, Hui, Yu, Chenguang, Franzblau, Scott G, Petrassi, H Mike, Jacobs, William R, Jr, Rubin, Harvey, Chatterjee, Arnab K, Wang, Feng, 2018
  • Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes, Liu R, 2017
  • Genetically encoding phosphotyrosine and its nonhydrolyzable analog in bacteria, Luo, Xiaozhou, Fu, Guangsen, Wang, Rongsheng E, Zhu, Xueyong, Zambaldo, Claudio, Liu, Renhe, Liu, Tao, Lyu, Xiaoxuan, Du, Jintang, Xuan, Weimin, Yao, Anzhi, Reed, Sean A, Kang, Mingchao, Zhang, Yuhan, Guo, Hui, Huang, Chunhui, Yang, PengYu, Wilson, Ian A, Schultz, Peter G, Wang, Feng, 2017
  • Engineering Bifunctional Antibodies with Constant Region Fusion Architectures, Du, Juanjuan, Cao, Yu, Liu, Yan, Wang, Ying, Zhang, Yong, Fu, Guangsen, Zhang, Yuhan, Lu, Lucy, Luo, Xiaozhou, Kim, Chan Hyuk, Schultz, Peter G, Wang, Feng, 2017
  • Multifunctional Antibody Agonists Targeting Glucagon-like Peptide-1, Glucagon, and Glucose-Dependent Insulinotropic Polypeptide Receptors, Wang, Ying, Du, Jintang, Zou, Huafei, Liu, Yan, Zhang, Yuhan, Gonzalez, Jose, Chao, Elizabeth, Lu, Lucy, Yang, Pengyu, Parker, Holly, Van NguyenTran, Shen, Weijun, Wang, Danling, Schultz, Peter G, Wang, Feng, 2016
  • Rational Design of Dual Agonist-Antibody Fusions as Long-acting Therapeutic Hormones, Liu, Yan, Wang, Ying, Zhang, Yong, Liu, Tao, Jia, Haiqun, Zou, Huafei, Fu, Qiangwei, Zhang, Yuhan, Lu, Lucy, Chao, Elizabeth, Parker, Holly, NguyenTran, Van, Shen, Weijun, Wang, Danling, Schultz, Peter G, Wang, Feng, 2016
  • Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant, Wang, Rongsheng E, Wang, Ying, Zhang, Yuhan, Gabrelow, Chase, Zhang, Yong, Chi, Victor, Fu, Qiangwei, Luo, Xiaozhou, Wang, Danling, Joseph, Sean, Johnson, Kristen, Chatterjee, Arnab K, Wright, Timothy M, NguyenTran, Van T B, Teijaro, John, Theofilopoulos, Argyrios N, Schultz, Peter G, Wang, Feng, 2016
  • Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists, Liu, Tao, Zhang, Yong, Liu, Yan, Wang, Ying, Jia, Haiqun, Kang, Mingchao, Luo, Xiaozhou, Caballero, Dawna, Gonzalez, Jose, Sherwood, Lance, Nunez, Vanessa, Wang, Danling, Woods, Ashley, Schultz, Peter G, Wang, Feng, 2015
  • Rational Design of Humanized Dual-Agonist Antibodies, Zhang, Yong, Liu, Yan, Wang, Ying, Schultz, Peter G, Wang, Feng, 2015
  • Rational Design of Antibody Protease Inhibitors, Liu, Tao, Fu, Guangsen, Luo, Xiaozhou, Liu, Yan, Wang, Ying, Wang, Rongsheng E, Schultz, Peter G, Wang, Feng, 2015
  • Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody, Zhang, Yong, Zou, Huafei, Wang, Ying, Caballero, Dawna, Gonzalez, Jose, Chao, Elizabeth, Welzel, Gus, Shen, Weijun, Wang, Danling, Schultz, Peter G, Wang, Feng, 2015
  • Homogeneously modified immunoglobulin domains for therapeutic application, Liu, Tao, Du, Juanjuan, Luo, Xiaozhou, Schultz, Peter G, Wang, Feng, 2015
  • An Immunosuppressive Antibody-Drug Conjugate, Wang, Rongsheng E, Liu, Tao, Wang, Ying, Cao, Yu, Du, Jintang, Luo, Xiaozhou, Deshmukh, Vishal, Kim, Chan Hyuk, Lawson, Brian R, Tremblay, Matthew S, Young, Travis S, Kazane, Stephanie A, Wang, Feng, Schultz, Peter G, 2015
  • Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis, Harbut, Michael B, Vilcheze, Catherine, Luo, Xiaozhou, Hensler, Mary E, Guo, Hui, Yang, Baiyuan, Chatterjee, Arnab K, Nizet, Victor, Jacobs, William R, Jr, Schultz, Peter G, Wang, Feng, 2015
  • An Antibody with a Variable-Region Coiled-Coil 'Knob' Domain, Zhang, Yong, Goswami, Devrishi, Wang, Danling, Wang, TsungShing Andrew, Sen, Shiladitya, Magliery, Thomas J, Griffin, Patrick R, Wang, Feng, Schultz, Peter G, 2014
  • Rational Design of CXCR4 Specific Antibodies with Elongated CDRs, Liu, Tao, Liu, Yan, Wang, Ying, Hull, Mitchell, Schultz, Peter G, Wang, Feng, 2014
  • Reshaping Antibody Diversity, Wang, Feng, Ekiert, Damian C, Ahmad, Insha, Yu, Wenli, Zhang, Yong, Bazirgan, Omar, Torkamani, Ali, Raudsepp, Terje, Mwangi, Waithaka, Criscitiello, Michael F, Wilson, Ian A, Schultz, Peter G, Smider, Vaughn V, 2013
  • An Antibody CDR3-Erythropoietin Fusion Protein, Zhang, Yong, Wang, Danling, Welzel, Gus, Wang, Ying, Schultz, Peter G, Wang, Feng, 2013
  • Correction for Wang et al., Identification of a small molecule with activity against drug-resistant and persistent tuberculosis, Not mentioned, 2013
  • Functional Antibody CDR3 Fusion Proteins with Enhanced Pharmacological Properties, Zhang, Yong, Wang, Danling, de Lichtervelde, Lorenzo, Sun, Sophie B, Smider, Vaughn V, Schultz, Peter G, Wang, Feng, 2013
  • Structural and functional insights into lipid-bound nerve growth factors, Tong, Qiong, Wang, Feng, Zhou, HongZhe, Sun, HanLi, Song, Hui, Shu, YuYan, Gong, Yong, Zhang, WenTing, Cai, Tanxi, Yang, FuQuan, Tang, Jie, Jiang, Tao, 2012
  • Crystallization and preliminary X-ray diffraction analysis of three mastoparans, Wang, Feng, Liu, Xiaoqin, Li, He, Lang, Xianjun, Peng, Hui, Liu, Shenquan, Jiang, Tao, 2006
  • An Epitope-Specific Respiratory Syncytial Virus Vaccine based on an Antibody Scaffold, Luo Xiaozhou, Liu Tao Dr., Wang Ying Dr., Jia Haiqun Dr., Zhang Yuhan, Caballero Dawna, Du Juanjuan Dr., Wang Rongsheng E. Dr., Wang Danling Dr., Schultz Peter G., Wang Feng Dr., 2013
Antibody Engineering Chemical Biology Biophysics Pharmacology Immunology Protein Therapeutic Development

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.